“…12,13 In line with previous studies, 12 the authors found significant effects on small airway measurements (R5eR20) during standardized bronchial challenge testing. Small airway dysfunction within asthma is becoming recognized as a distinct clinical phenotype associated with poor asthma control.…”
“…12,13 In line with previous studies, 12 the authors found significant effects on small airway measurements (R5eR20) during standardized bronchial challenge testing. Small airway dysfunction within asthma is becoming recognized as a distinct clinical phenotype associated with poor asthma control.…”
“…24 In another study comparing asthmatic patients with and without symptoms who underwent a methacholine challenge, the symptomatic group exhibited a significantly greater change in R5-20 and AX values after challenge. 25 Our patients had stable mild-to-moderate persistent asthma, as reflected by the mean value of 0.76 for ACQ scores at initial screening, which is close to the 0.75 cutoff value for wellcontrolled disease. 19 The normal mean FENO value of 27 ppb at screening is indicative of the suppressive effects of ICSs at a mean beclomethasone-equivalent dose of 550 mg/d.…”
Significant improvements in IOS outcomes but not spirometry results occurred after chronic dosing with formoterol compared with salmeterol. This might reflect better deposition to the entire lung, including the small airways.
“…Patients with symptoms had worse PAW function (R5–R20 and X5) pre and post challenge in comparison to asymptomatic patients, with there being no difference in either R20 or FEV1, which primarily reflect the central airways (72) .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.